Hypermethylation of O6-Methylguanine-DNA Methyltransferase Promoter May Predict Nonrecurrence after Chemotherapy in Colorectal Cancer Cases

Clinical Cancer Research

Volumn 9, Issue 14, 2003, Pages 5306-5312

  Nagasaka, Takeshi ^a   Sharp, Gerald B ^b   Notohara, Kenji ^a   Kambara, Takeshi ^a   Sasamoto, Hiromi ^a   Isozaki, Hiroshi ^a   MacPhee, Donald G ^b   Jass, Jeremy R ^c   Tanaka, Noriaki ^a   Matsubara, Nagahide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ACTIVITY; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; FEMALE; GENE SILENCING; HUMAN; HUMAN TISSUE; HYPERMETHYLATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; PREDICTION AND FORECASTING; RECTUM; TUMOR RECURRENCE;

AGED; COLON; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS (GENETICS); RECTUM;

EID: 0242610375     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50: 6119-6129, 1990.
2. 6-alkylguanine. FASEB J., 6: 2302-2310, 1992.
3. Coulondre, C., and Miller, J. H. Genetic studies of the lac repressor. III. Additional correlation of mutational sites with specific amino acid residues. J. Mol. Biol., 117: 525-567, 1977.
4. Hickman, M. J., and Samson, L. D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. USA, 96: 10764-10769, 1999.
5. 6-Alkylguanine DNA lesions trigger apoptosis. Carcinogenesis (Lond.), 19: 369-372, 1998.
6. D'Atri, S., Tentori, L., Lacal, P. M., Graziani, G., Pagani, E., Benincasa, E., Zambruno, G., Bonmassar, E., and Jiricny, J. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol. Pharmacol., 54: 334-341, 1998.
7. 6-Methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary. Cancer Res., 51: 4131-4134, 1991.
8. 6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. Proc. Natl. Acad. Sci. USA, 93: 6941-6946, 1996.
9. 6-alkylguanine-DNA alkyltransferase expression in human brain tumors: possible significance in nitrosourea therapy. Carcinogenesis (Lond.), 17: 637-641, 1996.
10. Day, R. S., III, Ziolkowski, C. H., Scudiero, D. A., Meyer, S. A., Lubiniecki, A. S., Girardi, A. J., Galloway, S. M., and Bynum, G. D. Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature (Lond.), 288: 724-727, 1980.
11. 6-methylguanine-DNA methyltransferase in human Mer+ and Mer- cells. Carcinogenesis (Lond.), 16: 1857-1863, 1995.
12. 6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res., 61: 827-830, 2001.
13. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res., 59: 793-797, 1999.
14. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res., 60: 2368-2371, 2000.
15. 6-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer (Phila.), 92: 2760-2768, 2001.
16. 6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J. Natl. Cancer Inst. (Bethesda), 94: 26-32, 2002.
17. Kambara, T., Matsubara, N., Nakagawa, H., Notohara, K., Nagasaka, T., Yoshino, T., Isozaki, H., Sharp, G. B., Shimizu, K., Jass, J., and Tanaka, N. High frequency of low-level microsatellite instability in early colorectal cancer. Cancer Res., 61: 7743-7746, 2001.
18. Herfarth, K. K., Brent, T. P., Danam, R. P., Remack, J. S., Kodner, I. J., Wells, S. A., Jr., and Goodfellow, P. J. A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol. Carcinog., 24: 90-98, 1999.
19. Bartsch, H., Ohshima, H., Shuker, D. E., Pignatelli, B., and Calmels, S. Exposure of humans to endogenous N-nitroso compounds: implications in cancer etiology. Mutat. Res., 238: 255-267, 1990.
20. Rowland, I. R., Granli, T., Bockman, O. C., Key, P. E., and Massey, R. C. Endogenous N-nitrosation in man assessed by measurement of apparent total N-nitroso compounds in faeces. Carcinogenesis (Lond.), 12: 1395-1401, 1991.
21. Ward, F. W., Coates, M. E., and Walker, R. Influence of dietary protein and gut microflora on endogenous synthesis of nitrate and N-nitrosamines in the rat. Food Chem. Toxicol., 27: 445-449, 1989.
22. 6-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res., 61: 4689-4692, 2001.
23. Hall, C. N., Badawi, A. F., O'Connor, P. J., and Saffhill, R. The detection of alkylation damage in the DNA of human gastrointestinal tissues. Br. J. Cancer. 64: 59-63, 1991.
24. 6-benzylguanine on the antitumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloro-ethyl-1-nitrosourea in mice. Br. J. Cancer, 79: 1332-1339, 1999.